Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Rampton

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Gut|March 15, 2000
Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paperE Carty, M De Brabander, R M Feakins, et al.
Clinical Nephrology|December 1, 1992
Effects of indomethacin and misoprostol on renal function in healthy volunteersM E Wilkie, G R Davies, F P Marsh, et al.
Alimentary Pharmacology & Therapeutics|January 5, 2011
Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosisJ R Goodhand, N Kamperidis, H Nguyen, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsiesN J Simmonds, A D Millar, D R Blake, et al.
Gut|January 23, 1999
Diversion colitis: a trigger for ulcerative colitis in the in-stream colon?A G Lim, F L Langmead, R M Feakins, et al.
Gastroenterology|April 1, 1994
Platelets circulate in an activated state in inflammatory bowel diseaseC E Collins, M R Cahill, A C Newland, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trialA D de Silva, E Tsironi, R M Feakins, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2001
Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's diseaseE Carty, D S Rampton, H Schneider, et al.
International Journal of Colorectal Disease|September 1, 2005
Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literatureA I Haq, A Sahai, S Hallwoth, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1996
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel diseaseC E Collins, M J Benson, W R Burnham, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Gut|March 15, 2000
Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paperE Carty, M De Brabander, R M Feakins, et al.
Clinical Nephrology|December 1, 1992
Effects of indomethacin and misoprostol on renal function in healthy volunteersM E Wilkie, G R Davies, F P Marsh, et al.
Alimentary Pharmacology & Therapeutics|January 5, 2011
Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosisJ R Goodhand, N Kamperidis, H Nguyen, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsiesN J Simmonds, A D Millar, D R Blake, et al.
Gut|January 23, 1999
Diversion colitis: a trigger for ulcerative colitis in the in-stream colon?A G Lim, F L Langmead, R M Feakins, et al.
Gastroenterology|April 1, 1994
Platelets circulate in an activated state in inflammatory bowel diseaseC E Collins, M R Cahill, A C Newland, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trialA D de Silva, E Tsironi, R M Feakins, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2001
Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's diseaseE Carty, D S Rampton, H Schneider, et al.
International Journal of Colorectal Disease|September 1, 2005
Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literatureA I Haq, A Sahai, S Hallwoth, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1996
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel diseaseC E Collins, M J Benson, W R Burnham, et al.
Pageof 13